Publications by authors named "Ruth Frampton"

Claim this Profile
T
Tirzepatide in Adults With Type 1 Diabetes: A Phase 2 Randomized Placebo-Controlled Clinical Trial.
Jennifer R Snaith, Ruth Frampton, Dorit Samocha-Bonet, Jerry R Greenfield

Diabetes Care· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting cardiometabolic risk in type 1 diabetes through incretin physiology.
Ruth Frampton, Samantha Hocking, Jennifer R Snaith, Jerry R Greenfield

Trends Endocrinol Metab· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Cardioprotective Adjuncts in Type 1 Diabetes.
Jerry R Greenfield, Ruth Frampton, Kellie Millard, Jennifer R Snaith

Diabetes Ther· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoglycaemia following physical exercise in a patient with novel SLC16A1 variant.
Ruth Frampton, David Lewis, Yusof Rahman, Michel Tchan, Jerry R Greenfield

Eur J Endocrinol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing cardiometabolic risk with semaglutide in type 1 diabetes (RESET1): Study protocol of a phase 2 double-blinded randomised placebo-controlled trial.
Ruth Frampton, Jennifer R Snaith, Samantha Hocking, Jane Holmes-Walker, Nicholas Olsen

Diabet Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis